Gilead Sciences
GILD
#98
Rank
$169.22 B
Marketcap
$136.34
Share price
1.56%
Change (1 day)
22.54%
Change (1 year)

Gilead Sciences (GILD) - Cash on Hand

Cash on Hand as of December 2025 : $9.61 Billion USD

According to Gilead Sciences's latest financial reports the company has $9.61 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Gilead Sciences - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31$9.61 B-16.9%
2024-12-31$11.56 B59.25%
2023-12-31$7.26 B13.77%
2022-12-31$6.38 B-2.07%
2021-12-31$6.52 B-11.99%
2020-12-31$7.40 B-69.58%
2019-12-31$24.35 B-19.07%
2018-12-31$30.08 B17.95%
2017-12-31$25.51 B114.46%
2016-12-31$11.89 B-18.57%
2015-12-31$14.60 B44.22%
2014-12-31$10.12 B375.05%
2013-12-31$2.13 B14.49%
2012-12-31$1.86 B-81.19%
2011-12-31$9.90 B371.74%
2010-12-31$2.09 B26.66%
2009-12-31$1.65 B-7.43%
2008-12-31$1.79 B52.74%
2007-12-31$1.17 B25.1%
2006-12-31$0.93 B-59.46%
2005-12-31$2.31 B84.29%
2004-12-31$1.25 B77.37%
2003-12-31$0.70 B-24.98%
2002-12-31$0.94 B61.68%
2001-12-31$0.58 B13.64%
2000-12-31$0.51 B74.21%
1999-12-31$0.29 B191.19%
1998-12-31$0.10 B215.94%
1997-12-31$32 M-75.76%
1996-12-31$0.13 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
$20.10 B 109.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$13.59 B 41.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$5.25 B-45.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$7.26 B-24.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$9.12 B-5.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$3.81 B-60.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$1.63 B-83.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$6.60 B-31.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$14.56 B 51.51%๐Ÿ‡บ๐Ÿ‡ธ USA